GAGLIANO, Teresa
 Distribuzione geografica
Continente #
NA - Nord America 4.445
AS - Asia 1.877
EU - Europa 1.109
SA - Sud America 272
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 7.741
Nazione #
US - Stati Uniti d'America 4.373
SG - Singapore 793
CN - Cina 568
BR - Brasile 225
UA - Ucraina 206
DE - Germania 194
HK - Hong Kong 184
PL - Polonia 154
IT - Italia 145
GB - Regno Unito 114
TR - Turchia 114
FI - Finlandia 98
VN - Vietnam 88
SE - Svezia 76
RU - Federazione Russa 49
MX - Messico 36
CA - Canada 30
IN - India 27
AR - Argentina 19
FR - Francia 19
ID - Indonesia 19
ZA - Sudafrica 19
BD - Bangladesh 17
JP - Giappone 17
BE - Belgio 14
ES - Italia 12
IQ - Iraq 8
AT - Austria 6
EC - Ecuador 6
JO - Giordania 6
KE - Kenya 6
NL - Olanda 6
PK - Pakistan 6
CO - Colombia 5
VE - Venezuela 5
CL - Cile 4
PY - Paraguay 4
UZ - Uzbekistan 4
DZ - Algeria 3
LT - Lituania 3
MA - Marocco 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
IE - Irlanda 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
Totale 7.741
Città #
Ashburn 487
Fairfield 487
Singapore 449
Woodbridge 433
Chandler 311
Houston 276
Ann Arbor 246
Jacksonville 240
Beijing 219
Seattle 195
Santa Clara 189
Hong Kong 182
Warsaw 153
Wilmington 145
Cambridge 138
Los Angeles 86
Izmir 58
Addison 57
Princeton 55
Nanjing 54
Ferrara 53
New York 43
Boardman 41
Dallas 40
Munich 39
San Diego 36
Shanghai 36
Helsinki 32
Mexico City 27
Turku 25
Buffalo 24
São Paulo 23
Hanoi 21
Ho Chi Minh City 21
Milan 21
Denver 19
Falls Church 19
Shenyang 19
Washington 18
Jakarta 17
Tianjin 17
Tokyo 17
Johannesburg 16
Montreal 16
Nanchang 16
Bremen 15
Dearborn 15
Brooklyn 14
Changsha 14
Hebei 14
London 14
Mountain View 14
Brussels 13
Moscow 13
Atlanta 12
Frankfurt am Main 12
Jinan 12
Poplar 12
Stockholm 12
Auburn Hills 11
Chennai 10
Chicago 10
Manchester 10
Orem 10
Orange 9
The Dalles 9
Nuremberg 8
Rio de Janeiro 8
San Francisco 8
Augusta 7
Boston 7
Falkenstein 7
Guangzhou 7
Norwalk 7
Redwood City 7
Amman 6
Columbus 6
Dong Ket 6
Hải Dương 6
Jiaxing 6
Leawood 6
Toronto 6
Baghdad 5
Belo Horizonte 5
Bologna 5
Dhaka 5
Kunming 5
Nairobi 5
Phoenix 5
San Jose 5
Secaucus 5
Tappahannock 5
Amsterdam 4
Ankara 4
Biên Hòa 4
Brasília 4
Cagliari 4
Council Bluffs 4
Da Nang 4
Haiphong 4
Totale 5.561
Nome #
Cellular and molecular components of the atherosclerotic process: Primary colture and characterization of human vascular smooth muscle cells from carotid artery 257
Igf-I influences everolimus activity in medullary thyroid carcinoma 227
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 218
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 212
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 203
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 202
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 191
Functional characterization of a new deletion in CDKN1B 5'-UTR region 189
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 187
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 185
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 183
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 183
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 180
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 179
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 177
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 174
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 171
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 170
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR? 169
ATR kinase function is modulated by the proto-oncogene PBF 167
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 167
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 166
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 165
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 165
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 161
ATR kinase function is modulated by the proto-oncogene PBF 159
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 157
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 152
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 148
Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing 147
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 146
ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion 140
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 138
Calmodulin Is a Marker of a Distinct Smooth Muscle Cell Population Recruited by Plaque-Derived Macrophages from the Human Carotid Artery Media 134
The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells 134
Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling 130
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 123
Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line 122
LMTK3 confers chemo-resistance in breast cancer 116
Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line 112
Targeting PKC in human pancreatic neuroendocrine tumor cells 108
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 107
The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer 104
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 103
CDK-Inhibitors as New Therapeutic Treatment for Human Bronchial Carcinoids 102
miRNA transported by exosomes: A key machinery in tumor microenvironment mediated chemoresistance 100
EGFR and IGF1R Impair Sunitinib Activity and May Represent Novel Targets for Broncho-Pulmonary Neuroendocrine Neoplasm Treatment 95
Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line 92
null 92
null 81
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors 64
Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines 55
Totale 7.809
Categoria #
all - tutte 35.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021438 0 0 0 0 0 66 37 83 20 80 104 48
2021/2022491 32 31 21 11 32 46 20 16 20 54 35 173
2022/2023614 57 55 25 83 95 85 23 59 83 6 23 20
2023/2024314 29 34 23 6 26 51 9 47 5 3 4 77
2024/20251.216 22 30 94 21 179 148 47 37 206 126 169 137
2025/20261.856 312 113 243 396 583 209 0 0 0 0 0 0
Totale 7.809